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Abstract 21 
HIV in humans and SIV in macaques (MAC) lead to chronic inflammation and AIDS.  Natural 22 
hosts, such as African green monkeys (AGM) and sooty mangabeys (SM), are protected against 23 
SIV-induced chronic inflammation and AIDS. Here, we report that AGM plasmacytoid dendritic 24 
cells (pDC) express extremely low levels of CD4, unlike MAC and human pDC. Despite this, AGM 25 
pDC efficiently sensed SIVagm, but not heterologous HIV/SIV isolates, indicating a virus-host 26 
adaptation. Moreover, both AGM and SM pDC were found to be, in contrast to MAC pDC, 27 
predominantly negative for CCR5. Despite such limited CD4 and CCR5 expression, lymphoid 28 
tissue pDC were infected to a similar degree as CD4+ T cells, both in MAC and AGM. Altogether, 29 
our finding of efficient pDC infection by SIV in vivo identifies pDC as a potential viral reservoir in 30 
lymphoid tissues. We discovered low expression of CD4 on AGM pDC, which did not preclude 31 
efficient sensing of host-adapted viruses.  Therefore, pDC infection and efficient sensing are not 32 
prerequisites for chronic inflammation. The high level of pDC infection by SIVagm suggests that 33 
if CCR5 paucity on immune cells is important for non-pathogenesis of natural hosts, it is possibly 34 
not due to its role as a co-receptor. 35 
Importance 36 
The ability of certain key immune cell subsets to resist infection might contribute to the 37 
asymptomatic nature of simian immunodeficiency virus (SIV) infection in its natural hosts, such 38 
as African green monkeys (AGM) and sooty mangabeys (SM). This relative resistance to 39 
infection has been correlated with reduced expression of CD4 and/or CCR5. We show that 40 
plasmacytoid dendritic cells (pDC) of natural hosts display a reduced CD4 and/or CCR5 41 
expression, unlike macaque pDC. Surprisingly, this did not protect AGM pDC, as infection levels 42 
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were similar to those found in MAC pDC. Furthermore, we show that AGM pDC did not 43 
consistently produce IFN-I upon heterologous SIVmac/HIV-1 encounter, while they sensed 44 
autologous SIVagm isolates. Pseudotyping SIVmac/HIV-1 overcame this deficiency, suggesting 45 
that reduced uptake of heterologous viral strains underlay this lack of sensing. The distinct IFN-I 46 
responses depending on host species and HIV/SIV isolates reveal host/virus species-specificity of 47 
pDC sensing. 48 
Introduction 49 
Chronic inflammation and immune activation in HIV-infected individuals and in SIV-infected 50 
macaques (MAC) lead to depletion of CD4+ T cells and progression to AIDS. Natural hosts of SIV, 51 
such as African green monkeys (AGM) and sooty mangabeys (SM), do not display chronic 52 
inflammation or AIDS (1). This is due to resolution of inflammation before the end of acute 53 
infection, rather than to a lack of SIV recognition by the innate immune system (2). Natural 54 
hosts further differ from pathogenic HIV/SIV infections by exhibiting reduced infection rates in 55 
certain cell subsets, such as central memory CD4+ T cells (Tcm) (3, 4). This relative resistance has 56 
been linked to a reduced expression of the HIV/SIV co-receptor CCR5 on natural host CD4+ T 57 
cells and to a downmodulation of CD4 on activated CD4+ T cells in AGM (3-5).  58 
Plasmacytoid dendritic cells (pDC) form a rare cell population that is responsible for the vast 59 
majority of IFN-I production after HIV encounter (6). This is also true for AGM pDC as the 60 
depletion of pDC from AGM PBMC completely abrogates the IFN-I response to SIVagm 61 
stimulation (7). HIV/SIV sensing by pDC is mediated through endocytosis followed by TLR7/9 62 
engagement. It requires CD4, but is independent of co-receptor expression (6). Data on the 63 
infection rates of pDC in vivo are scarce. One study reported the presence of HIV DNA in 64 
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circulating pDC of chronically HIV-infected patients (8). Another study reported high infection 65 
levels in lymph node (LN) pDC during acute SIVmac infection (9).   66 
Here, we discovered a restricted CD4 and/or CCR5 expression on pDC in natural hosts. We 67 
evaluated the effect of low CD4 expression on the capacity of AGM pDC to efficiently sense 68 
distinct forms of SIVagm (free virus, non-infectious particles and SIVagm-infected cells). 69 
Furthermore, we examined the infection frequency of pDC during pathogenic and non-70 
pathogenic SIV infection. 71 
Materials and Methods 72 
Study Approval 73 
All animal experimental protocols were approved by either the Ethical Committee of Animal 74 
Experimentation (CETEA-DSV, IDF, France) (Notification numbers: 10-051b and 12-006) or by the 75 
Institutional Animal Care and Use Committees (IACUC) of Emory University (IACUC protocol 76 
#2000793, entitled “Comparative AIDS Program”). Animals were housed in the facilities of the 77 
CEA (“Commissariat à l'Energie Atomique”, Fontenay-aux-Roses, France, permit number: A 92-78 
032-02), Institut Pasteur (Paris, France, permit number: A 78-100-3) or Yerkes National Primate 79 
Research Center (Atlanta, GA, USA). All experimental procedures were conducted in strict 80 
accordance with the international European guidelines 2010/63/UE on protection of animals 81 
used for experimentation and other scientific purposes (French decree 2013-118) and with the 82 
recommendations of the Weatherall report or in strict accordance with USDA regulations and 83 
the recommendations in the Guide for the Care and Use of Laboratory Animals of the National 84 
Institutes of Health. The CEA complies with Standards for Human Care and Use of Laboratory of 85 
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the Office for Laboratory Animal Welfare (OLAW, USA) under OLAW Assurance number #A5826-86 
01. The monitoring of the animals was under the supervision of the veterinarians in charge of 87 
the animal facilities.  88 
In vivo infections and sample collection 89 
Twenty-six African green monkeys (Chlorocebus sabaeus) of the sabaeus species with a 90 
Caribbean origin, eightteen Chinese rhesus macaques (Macaca mulatta), two cynomolgous 91 
macaques (Macaca fascularis), sixteen Indian rhesus macaques (Macaca mulatta) and sixteen 92 
sooty mangabeys (Cercocebus atys) were used in this study. Eleven AGMs were infected via 93 
intravenous inoculation with 250 TCID50 of SIVagm.sab92018, as described previously (10, 11). 94 
Four Chinese rhesus macaques were i.v. infected with 50 AID50 SIVmac251 and two others were 95 
infected with 5000 AID50 SIVmac251, as described previously (10, 12). Eight Indian rhesus 96 
macaques had been previously infected with SIVmac239 or SIVmac251 and eight sooty 97 
mangabeys were either naturally infected or infected experimentally with SIVsmE041 (13, 14). 98 
Blood was collected by venipuncture on sodium heparin tubes and shipped to Institut Pasteur or 99 
used on site at Yerkes National Primate Research Center. Bone marrow mononuclear cells were 100 
isolated on Ficoll and tissue cells were put in suspension before staining. LNs and spleens were 101 
disrupted mechanically and rectal tissues were enzymatically degraded as described previously 102 
(12, 15). 103 
Viral stimulations 104 
Freshly isolated PBMCs were cultured at 0.5x106 cells/well in 24-well plates (Costar) at 37˚ C, 5% 105 
CO2 for eighteen hours with or without virus. Cell viability was measured using trypan blue and a 106 
Countess (Life Technologies) cell counter. The SIVagm strains used, have been previously 107 
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described: SIVagm.sab92018 (11), SIVagm.sabD46 and SIVagm.tanB14 (16), SIVagm.sab1c (11, 108 
17) and SIVgri1 (18, 19). Free SIVagm was added to PBMCs at a concentration of 1500 ng/mL 109 
p27, unless indicated otherwise. HSV-1 was added at a TCID50 of 2x105. HIV-1.Bal-VSV, which is 110 
endocytosed independently of CD4 (20), was kindly provided by A. David and AT2-inactivated 111 
SIVagm as well as control microvesicles by Dr. Jeff Lifson (National Cancer Institute, Frederick, 112 
MD). SIVmac251-VSV was produced by co-transfecting 293T cells with SIVmac251Δenv and VSV-113 
G expression vector using SuperFect (Qiagen), as described previously (21).  SIVagm isolates 114 
were grown on SupT1 cells, as these cells express Bonzo and are susceptible to SIVagm while 115 
SIVmac isolates were grown on CEMx174 as these cells express Bob and are susceptible to 116 
SIVmac (22). 117 
Production of infected cells 118 
Cells were infected as previously described (23). Briefly, SupT1 cells were exposed for one hour 119 
at 37˚ C to 3.3x104 TCID50 per 106 cells under constant agitation. Infection levels were assessed 120 
by measuring SIV Gag+ cells using flow cytometry (see below). 121 
Functional Interferon alpha assay 122 
Bioactive IFN-I levels were quantified as described earlier (7). In short, Mardin-Darby Bovine 123 
Kidney (MDBK) cells were incubated with UV-inactivated supernatants for 18 hours, after which 124 
the cytopathic effect of vesicular stomatic virus was determined using the CellTiter 96® 125 
AQueous Non-Radioactive Cell Proliferation Assay (Promega). Alternatively, a cell line stably 126 
transfected with a luciferase gene under an IFN-I inducible promoter was used to measure IFN-I 127 
levels, as described previously (23). The limit of detection threshold was set at 2 IU/mL. 128 
Flow cytometry 129 
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SM flow cytometric data were acquired at Yerkes National Primate Center and data for AGM 130 
were acquired at Institut Pasteur. MAC data were acquired at both Yerkes and Pasteur, with 131 
similar results. The following antibodies were used to identify and characterize pDC phenotype 132 
and function in whole blood or isolated tissue cells: CD3 (SP34-2), CD4 (L200), HLA-DR (L243), 133 
CCR5 (3A9), CD123 (7G3) (all BD Biosciences), CD20 (2H7, ebioscience), CD4 (M-T466), BDCA-2 134 
(AC144) (all Miltenyi) and CD4 (SFCI12T4D11, Beckman Coulter). FcR Blocking Reagent (Miltenyi) 135 
was used to block unspecific antibody binding and in experiments using tissues other than 136 
blood, Live/Dead cell viability (Invitrogen) was used to exclude dead cells. For intracellular 137 
staining, cells were labeled with surface-binding antibodies and fixed with 4% 138 
paraformaldehyde and permeabilized using saponin prior to incubation with anti-CD4. For 139 
intracellular SIVagm detection, anti-p24 staining (KC57, Beckman Coulter) was used after cell 140 
permeabilization with the IntraPrep Permeabilization Reagent Kit (Beckman Coulter) according 141 
to manufacturer’s instructions (23). Events ranging from one hundred to one thousand pDC 142 
were collected on a BD LSR-II flow cytometer, running BD FACS Diva 6.0 software, and analyzed 143 
with FlowJo 9.4.10 (TreeStar). Anti-mouse compensation beads (BD Biosciences) and Arc Amine 144 
Reactive Compensation Bead Kit (Life Technologies) were used to define compensation levels. 145 
An isotype control antibody was used to define CCR5+ cells. 146 
Cell sorting 147 
Splenocytes were frozen in 10% DMSO in liquid nitrogen until use. Cells were thawed in the 148 
presence of DNAse I (10 IU/mL, Roche) and washed in FCS. Cells were labeled with antibodies 149 
against CD3, CD20, HLA-DR, CD4, CD123 and with Live/Dead reagent in the presence of FcR 150 
Blocking Reagent. Cells were  sorted using a FACSAria II sorter (BD), running on BD FACS Diva 6.0 151 
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software. Sorted pDC and CD4+ T cells were purified a second time to increase purity of the two 152 
fractions. CD4+ T cells were also isolated from LNs cells using anti-CD4 beads and magnetic 153 
stands (Miltenyi) following manufacturer’s protocol, after which purity was verified by flow 154 
cytometry. 155 
SIV DNA quantification 156 
DNA was extracted as follows: samples were lysed in NaCl (3M), EDTA (0.5M, pH 8), SDS (10%, 157 
Bio-Rad) and proteinase K (1mg/mL, Qiagen) in a 45 min incubation at 55 ° C. Then, NaCl (5M) 158 
was added and incubated at 4 ° C between 15 and 60 min,  followed by centrifugation for 15 159 
min at 3000 rpm at 4 ° C. DNA was then precipitated from the supernatant in 160 
phenol:chloroform:isoamyl alcohol 25:24:1 (pH = 8, Sigma Aldrich). After DNA extraction, viral 161 
DNA was measured by qPCR in duplicate, using primers and probes designed specifically for 162 
SIVagm.sab and SIVmac (11, 15). SIVagm and SIVmac plasmids were used as standards to 163 
calculate SIV DNA copy numbers. CCR5 DNA quantification was used to normalize the viral levels 164 
to the number of cells (24). Sample preparation, enzyme mix preparation and PCR set-up were 165 
performed in three separate rooms to avoid PCR contamination. Positive and negative controls 166 
were used to exclude sample contamination.  167 
Fluorescence microscopy 168 
Fluorescence microscopy was done as follows with markers against NKp30 (AF29-4D12, 169 
Miltenyi), CD123 (5B11, Biolegend), DAPI and SIVagm env RNA (made from the region amplified 170 
by 5’-GAG GCT TGT GAT AAA ACT TAT TGG GAT-3’ and 5’-AGA GCA GTG ACG CGG GCA TTG 171 
AGG-3’ primers and labeled with fluorochrome Alexa 488 (Life Technologies)). Briefly, 172 
cryopreserved sections were permeabilized by incubating in 0.5% (v/v) Triton X-100. This was 173 
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followed by hybridization of probe and mounted antibodies on tissue. Secondary antibodies 174 
were used with to visualize the bound antibodies. Donkey anti-mouse IgG-CFL 594 (Santa Cruz) 175 
was used to detect CD123 and Zenon Alexa Fluor 647 Mouse IgG1 Labeling Kit (Life 176 
technologies) to reveal the NKP30 antibody. As negative controls for SIV RNA in situ 177 
hybridization, we used a RNAse degraded probe, taken up in hybridization buffer, as well as 178 
lymph nodes of uninfected animals.  Images were acquired on a Confocal Laser Scanning 179 
Microscope Leica TCS SP8, running LAS AF 3 (Leica Application Suite Advanced Fluorescence).  180 
Statistics 181 
Statistical inference analyses were performed using Prism 5.0 (GraphPad). The non-parametric 182 
Wilcoxon signed rank test and Mann-Whitney test were used to test paired and non-paired 183 
observations, respectively. In case of multiple testing of unpaired data, a non-parametric 184 
Kruskal-Wallis test, followed by a Dunn’s multiple comparison test, was used. Multiple testing of 185 
paired data without missing values was done by a Friedman test, followed by a Dunn’s multiple 186 
comparison test.  187 
Results 188 
Low CD4 expression on AGM pDC 189 
Given the importance of CD4 for HIV/SIV sensing by pDC, we measured CD4 on pDC from 190 
uninfected AGM, SM and MAC (Figure 1). PDC were defined as CD3-CD20-HLA-DR+CD123hi cells 191 
(Figure 2A) (2). MAC and SM pDC displayed similar CD4 levels as on CD4+ T cells (Figure 1A and 192 
B). Surprisingly, AGM pDC expressed CD4 at >1 log lower levels than CD4+ T cells (p < 0.001).  193 
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As (i) CD4 MFI on CD4+ T cells was similar between AGM and MAC and (ii) two additional CD4 194 
antibody clones confirmed low CD4 expression on AGM pDC (Figure 2B), it is unlikely that low 195 
CD4 on AGM pDC was due to species-specific antibody issues. The absence of intracellular CD4 196 
in AGM pDC indicated that recycling from the cell surface was not the underlying mechanism of 197 
this low expression (Figure 2C). AGM pDC from primary, secondary and tertiary lymphoid tissues 198 
all expressed low levels of CD4 (Figure 2D).  199 
Efficient SIV-sensing by AGM pDC 200 
The low CD4 expression on AGM pDC is paradoxical, since CD4 is essential for HIV/SIV sensing by 201 
pDC and AGM pDC have been shown to efficiently sense SIVagm (7, 12). Nonetheless, a lower 202 
production of IFN-I has been described during SIVagm infection in vivo (12, 25). We wondered 203 
whether low CD4 on pDC could have subtle effects on SIV sensing in vivo. For instance, only 204 
sensing of infectious SIVagm particles has been investigated (12, 25), while (i) most virions 205 
produced in vivo are non-infectious and (ii) sensing of virus-infected cells is more efficient in 206 
human and MAC (23). We stimulated peripheral blood mononuclear cells (PBMC) of a large 207 
number of uninfected AGM and MAC with infectious SIV, using HSV as a control for CD4-208 
independent sensing. No quantitative differences in IFN-I production were observed between 209 
AGM and MAC (Figure 3A). Both SIV-infected cells and AT2-inactivated SIVagm also induced 210 
normal IFN-I responses (Figures 3B and 3C). Longitudinal measurement showed that CD4 levels 211 
on pDC did not further decrease during SIV infection (Figure 3D). Altogether, these data 212 
demonstrate that low CD4 on AGM pDC did not impair their capacity to sense SIVagm. 213 
SIV isolate-dependent sensing of AGM pDC 214 
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We wondered how SIVagm is sensed by pDC despite low CD4 expression. CD4 is a highly 215 
polymorphic molecule among primates. We raised the hypothesis that given the long circulation 216 
of SIVagm in the AGM population, SIVagm is well-adapted to AGM CD4 (26). This could entail 217 
that SIVagm, but not heterologous viruses, can elicit robust IFN-I responses by AGM pDC. We 218 
tested this hypothesis by stimulating AGM (sabaeus) and MAC PBMC with nine SIV/HIV isolates 219 
(Figure 4A, B). The three SIVagm.sab isolates and the SIVagm.tan isolate induced robust IFN-I 220 
production by AGM pDC. SIVagm.gri did not induce an efficient response, which corresponds 221 
with the observation that the CD4 genes of the sabaeus and tantalus AGM species are more 222 
closely related to each other than to the CD4 gene of the grivet AGM species (26).  223 
In contrast, HIV-1 and two out of three SIVmac (SIVmac.251 and SIVmac.STM) isolates did not 224 
induce robust IFN-I production by AGM pDC (p < 0.05 or p < 0.01), even at a high viral dose. Only 225 
SIVmac239 induced IFN-I production from AGM PBMC, already at a low viral dose. Low dose of 226 
SIVmac239 also induced high levels of IFN-I in by MAC PBMC. At the highest dose, SIVmac239 227 
was more cytotoxic for AGM PBMC than SIVmac251 (p < 0.05, Figure 4C). However, at a dose of 228 
150 ng/mL p27, SIVmac239 did not influence viability, so it is unlikely that the strong response 229 
to SIVmac239 was related to dying cells, which are known to induce IFN-I responses (Figure 4C). 230 
It should be noted that SIVmac239 has been shown to be highly virulent in vivo compared to 231 
SIVmac251 (27). In contrast to AGM pDC, MAC pDC produced IFN-I upon stimulation with all 232 
SIV/HIV isolates, including SIVagm (Figure 4B).  233 
If the lack of SIVmac/HIV sensing by AGM pDC is indeed due to low CD4, then forcing viral 234 
endocytosis should overcome this sensing deficiency. In line with this, HIV-1, or SIVmac251, 235 
pseudotyped with VSV-G were sensed similar to SIVagm (Figure 4D). Indeed, pseudotyped HIV-1 236 
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and SIVmac251 induced higher levels of IFN-I than their wild-type isolates (p < 0.05 and p < 0.01, 237 
respectively, Figure 4D). Altogether, these findings indicate a virus-host co-adaptation in AGM 238 
for viral sensing by pDC. 239 
Predominance of CCR5 negative pDC in natural hosts 240 
We next examined CCR5 expression on AGM pDC, since co-receptor expression, in addition to 241 
CD4, is essential for infection. MAC pDC were predominantly CCR5+ (median 92.3%), while the 242 
majority of AGM and SM pDC did not express detectable levels of CCR5 (7.7% and 40% CCR5+ 243 
pDC, respectively; Figure 1A and 1C). In SMs, the percentage of CCR5+ pDC was lower after SIV 244 
infection (18.4%, p = 0.02; Figure 1C).  245 
PDC are highly infected during pathogenic and non-pathogenic SIV infection  246 
We then addressed the question if these reduced CD4 and CCR5 expressions associate with low 247 
infection of AGM pDC. To test this, we purified splenic pDC and CD4+ T cells of chronically SIV-248 
infected AGM and MAC and measured cell-associated viral DNA. Cells from uninfected animals 249 
were never positive for viral DNA (data not shown). Spleen pDC and CD4+ T cells from MAC 250 
harbored a median of 8.1 x 104 and 9.2 x 103 copies per million cells, respectively  (p = 0.37, 251 
Figure 5A). AGM harbored 3.2 x 104 and 4.1 x 103 copies per million splenic pDC and CD4+ T 252 
cells, respectively (p = 0.44, Figure 5A). AGM and MAC pDC were thus infected to a similar 253 
extent in vivo. As infection levels were similar between pDC and CD4+ T cells, potentially 254 
contaminating CD4+ T cells in the pDC fraction cannot explain the levels of detected SIV DNA in 255 
pDC. As pDC have limited phagocytic capacities, the high levels of viral DNA in these cells are 256 
also unlikely to be associated with engulfed infected T cells.  257 
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To further demonstrate the infection status of AGM pDC, we immunohistochemically examined 258 
a LN of a chronically infected AGM (Figure 5B). CD123 and SIVagm RNA signals overlapped, 259 
while NKp30, which is not expressed on pDC, did not co-stain with CD123 or SIVagm RNA.  260 
We then measured CD4 and CCR5 expression on splenic pDC of chronically infected AGM and 261 
MAC to exclude phenotypic differences compared to pDC from blood or from lymphoid tissues 262 
of uninfected animals. Splenic pDC of SIV-infected AGM, but not MAC, expressed low levels of 263 
CD4 (Figure 6). Only 4.7% of AGM splenic pDC had detectable CCR5 expression, while 92.9% of 264 
MAC splenic pDC were CCR5+ (p = 0.0079).  In conclusion, pDC of AGM and MAC were infected 265 
at high levels despite a restricted CD4 and CCR5 expression on AGM pDC.  266 
Discussion 267 
Such low CD4 expression as the one we discovered on AGM pDC is remarkable given the 268 
evolutionary conserved high expression of CD4 on mammalian pDC, including primate, murine, 269 
cattle and swine pDC (6, 28, 29). The role of CD4 in pDC biology is currently unknown, but this 270 
low expression raises questions on the physiological impact for AGM. The low CD4 levels on pDC 271 
were sufficient to allow SIVagm endocytosis and subsequent sensing and we demonstrated for 272 
the first time that natural host pDC can sense SIV-infected cells. In contrast, most SIVmac and 273 
HIV-1 isolates tested were not sensed by AGM pDC. Pseudotyping increased the efficiency of 274 
HIV-1/SIVmac251 sensing, which indicates that inefficient sensing of heterologous virus was due 275 
to restricted viral uptake. Altogether, this suggests an adaptation between SIVagm and its host-276 
specific CD4. Similar to our findings, it has been shown that HIV-1 poorly interacts with MAC 277 
CD4 compared to human CD4 and that HIV-1 could thus infect cells expressing low levels of 278 
human CD4, but not cells expressing low levels of MAC CD4 (30). Low CD4 expression also did 279 
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not prevent AGM pDC from being infected as they were infected at high levels in vivo. Since the 280 
pDC sensing capacity and infection levels were similar between AGM and MAC, these factors do 281 
not determine the level of chronic inflammation.    282 
Our study reveals a high infection rate of pDC in secondary lymphoid tissue during chronic SIV 283 
infection. These data resemble those of acute SIVmac infection, where pDC were found to be 284 
infected to similar levels as CD4+ T cells in LN (9). Since only very few data on pDC infection in 285 
vivo are available, this is important and underlines the potential role of pDC as a viral reservoir. 286 
Of note, the ratio of pDC to CD4+ T cells is low, approximately 1:300 in lymph nodes (2). 287 
Therefore, the majority of viral burden in SIV infection is still associated with CD4+ T cells. 288 
However the contribution of pDC should not be underestimated, given their presence in 289 
mucosae, their capacity to migrate to lymph nodes and their ability to efficiently transmit 290 
HIV/SIV to CD4+ T cells. 291 
The lack of correlation between the frequency of CCR5+ pDC and SIV infection status does not 292 
support the hypothesis that absence of CCR5 expression protects against target cell infection 293 
(4). In line with this, a mutation in the SM CCR5 allele, disrupting functional CCR5 expression, 294 
does not diminish SIVsm infection prevalence (31). This can be explained by the fact that SIVs, 295 
including SIVagm, efficiently use alternative co-receptors, such as CXCR6 (Bonzo) and GPR15 296 
(BOB) (22, 31). It is however possible that the low percentage of CCR5 expression in natural 297 
hosts is related indirectly to their resistance to disease. Indeed, while CCR5 is not a specific gut-298 
homing receptor, it can induce migration to inflamed tissues (14). Such extremely low levels of 299 
CCR5+ pDC in natural hosts could therefore be related to the lack of pDC accumulation in the gut 300 
after infection (32). Our results therefore suggest that evaluating the function of CCR5 in 301 
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seeding of viral reservoirs outside its role as a HIV co-receptor is warranted. Teasing out such 302 
mechanisms could be helpful for curative approaches. 303 
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Figure 1. CD4 and CCR5 expression on blood plasmacytoid dendritic cells. (A) CD4 and CCR5 443 
expression on pDC (blue) and Lineage+ cells (grey) of one representative Chinese cynomolgous 444 
macaque, African green monkey, sooty mangabey and Indian rhesus macaque. (B) CD4 445 
expression on pDC from SIV-negative Chinese rhesus macaques (n=8, open squares), Indian 446 
rhesus macaques (n=1, open upward triangles), AGM (n=13, open circles) and SM (n=11, filled 447 
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grey circles). CD4 mean fluorescent intensity (MFI) on pDC was normalized (%) to the CD4 MFI 448 
on CD4+ T cells. The horizontal, dashed line designates equal expression compared to CD4+ T 449 
cells. (C) The percentage of CCR5+ pDC was determined for SIV-negative Indian rhesus macaques 450 
(n = 11, open upward triangles), Chinese cynomolgous macaques (n = 2, open downward 451 
triangles), AGM (n = 7, open circles) and SM (n = 8, grey filled circles) and chronically SIV-452 
infected Indian rhesus macaques (n = 8, open upward triangles), AGM (n=3, open circles) and 453 
SM (n = 8, grey filled circles). Symbols represent individual animals and lines and bars represent 454 
medians and interquartile ranges. * Kruskal-Wallis, p < 0.05, *** Kruskal-Wallis, p < 0.001.  455 
Figure 2. Low CD4 expression on AGM pDCs. (A) Dot plots showing the gating strategy used to 456 
identify pDCs, which are FSC/SSC, singlets, Lineage (CD3/CD20)- cells and HLA-DR+ CD123hi cells, 457 
for one representative animal. (B) Low CD4 expression on AGM pDCs (n = 3) was confirmed 458 
using two additional monoclonal anti-CD4 antibodies (M-T466 and SFCI12T4D11). Histograms of 459 
representative animals are shown, depicting CD4 expression on CD4- cells (grey, solid), pDCs 460 
(blue, solid with contour) and Lineage+CD4+ cells (red, solid with contour). MFI values of CD4 for 461 
the three cell populations are shown in the table. (C) Intracellular and extracellular staining of 462 
AGM pDCs (n = 3).  Histograms of a representative animal are shown, cell surface expression 463 
CD4 expression is depicted for CD4- cells (grey, solid) and for pDCs, intracellular (blue, solid with 464 
contour) and extracellular (green, solid with contour) expression is shown, indicating an absence 465 
of an intracellular CD4 pool in AGM pDCs.  (D) Low CD4 expression was observed on pDCs from 466 
bone marrow (n = 1 AGM), LN (n = 1 AGM) and rectal biopsy (n = 1 AGM). Histograms depict 467 
CD4 expression on CD4- cells (grey, solid), pDCs (blue, solid with contour) and Lineage+ CD4+ cells 468 
(red, solid with contour). MFI values of CD4 are listed in the tables. 469 
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Figure 3. SIV sensing capacity of AGM pDCs. (A) SIVagm.sab92018 was used to stimulate AGM 470 
(n = 22) and SIVmac251 for Chinese rhesus MAC (n = 14) PBMCs. Alternatively, PBMCs were 471 
stimulated with HSV-1. (B) CD4 MFI was followed throughout SIVagm infection on four AGMs. 472 
Median and interquartile ranges are shown for CD4+ Lineage+ cells (red), pDCs (blue) and CD4- 473 
Lineage+ cells (grey).  (C) SIVagm-infected SupT1 cells and free virions were used to stimulate 474 
AGM PBMCs (n = 5). (D) SIVagm or AT2-inactivated SIVagm was used to stimulate AGM PBMCs 475 
(n = 8). Individual symbols represent distinct animals. Median and interquartile range are 476 
shown. Vertical dashes separate the different viral preparations used to test pDC sensing * 477 
Friedman, p < 0.05. 478 
Figure 4. Viral and host determinants of SIV sensing by pDC. PBMC from (A) AGM (n = 5-23) 479 
and (B) Chinese rhesus MAC (n = 2-15) were stimulated with medium (mock), five SIVagm, three 480 
SIVmac or HIV-1 (BAL) at three concentrations: 1500 ng/mL, 150 ng/mL and 15 ng/mL p24/p27. 481 
Median values are represented by a horizontal line (blue and red for SIVagm and HIV/SIVmac, 482 
respectively). * Wilcoxon, p < 0.05, ** Wilcoxon, p < 0.01, compared to equal dose 483 
SIVagm.sab92018 stimulation. nd = not determined. Tox = cytotoxic in 18 hour culture. (C) AGM 484 
PBMC (n=10) were stimulated with medium (grey circle), 15, 150 or 1500 ng/mL p27 SIVmac251 485 
(red square) or SIVmac239 (blue triangle) for 18 hours after which viability was measured. 486 
Median and interquartile ranges are depicted. * Wilcoxon, p < 0.05. (D) AGM PBMC were 487 
stimulated with HIV (n = 14), VSV-G pseudotyped HIV (n = 10), SIVmac251 (n = 10), VSV-G 488 
pseudotyped SIVmac251 (n=9) or SIVagm.sab92018 (n = 23) at 150 ng/mL p24 or p27. Median 489 
values and interquartile ranges are presented by a line and bars, respectively.  * Kruskal-Wallis, 490 
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p < 0.05, ** Kruskal-Wallis, p < 0.01, *** Kruskal-Wallis, p < 0.001. Symbols represent individual 491 
animals, horizontal dashed lines represent the limit of detection. 492 
Figure 5. In vivo pDC infection. (A) PDC and CD4+ T cells of chronically SIV-infected AGM (open 493 
circles, n = 7) and Chinese rhesus MAC (black circles, n = 5) were sorted from 2x108 to 4x108 494 
splenocytes, yielding a median of six thousand pDC after two subsequent sorts (purity 91%). 495 
CD4+ T cells were also purified from lymph node (LN) cells (purity 97%). SIV DNA was normalized 496 
to CCR5 and represented as copies per million cells.  Symbols represent individual animals. CD4+ 497 
T cells in LN were infected to a higher extent in MAC than AGM (* Mann-Whitney, p = 0.016). 498 
SIV DNA copy numbers were similar between spleen and LN CD4+ T in both species.  (B) 499 
Fluorescence microscopy was performed on a LN of one chronically infected AGM. DAPI (blue) 500 
shows nuclei, CD123 (yellow) is expressed on pDC, SIV RNA (red) shows infected cells and NKp30 501 
(green) is a marker not expressed on pDC. The merge shows an overlap from CD123 and SIV 502 
signals.  503 
Figure 6. CD4 and CCR5 expression on splenic AGM and MAC pDCs. (A) CD4 expression was 504 
measured on pDCs from spleen of chronically SIV infected Chinese rhesus MACs (n=5) and 505 
AGMs (n=5). The mean fluorescent intensity (MFI) of CD4 on splenic pDCs was normalized (%) to 506 
the CD4 MFI on splenic CD4+ T cells of the same animal. The horizontal, dashed line designates 507 
equal CD4 expression to CD4+ Lineage+ cells. Symbols represent individual animals and line and 508 
bars represent the median and interquartile range, respectively. (B) The percentage of CCR5+ 509 
splenic pDCs was determined for SIV-infected Chinese rhesus MACs (n = 5) and AGMs (n = 5). 510 
Symbols represent individual animals and the line and bars represent the median and 511 
interquartile range. ** Mann-Whitney, p < 0.01.  512 
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